A strategy for selective anti-cancer drug concentration increase in rat glioma tissue with Ca2+-channel blocker co-administration: Calcium kinetics in intra-glioma arteriolar smooth muscle cells

Journal of Neuro-Oncology

Volumn 30, Issue 1, 1996, Pages 25-36

  Zenke, Kiichiro ^a   Nakagawa, Koh ^a   Kumon, Yoshiaki ^a   Ohta, Shinsuke ^a   Hatakeyama, Takao ^a   Sakaki, Saburo ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood flow; C6 rat glioma; Ca2+ pyroantimonate; Ca2+ adenosine triphosphatase; Tyrphostin diltiazem

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DILTIAZEM; NIMUSTINE; PROTEIN TYROSINE KINASE; TYRPHOSTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BASAL GANGLION; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DRUG TISSUE LEVEL; ENZYME ACTIVITY; GLIOMA; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; TUMOR BLOOD FLOW; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTINEOPLASTIC AGENTS; ARTERIOLES; BRAIN NEOPLASMS; CALCIUM; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; GLIOMA; KINETICS; MALE; MUSCLE, SMOOTH, VASCULAR; NIMUSTINE; RATS; RATS, WISTAR; REFERENCE VALUES; REGIONAL BLOOD FLOW; TUMOR CELLS, CULTURED;

EID: 0029790570     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00177440     Document Type: Article

References (32)

1. 2+-AT-Pase activity. Acta Histochem Cytochem 14: 705-726, 1981
2. Baba T, Fukui M, Takeshita I, Ichiya Y, Kuwabara Y, Hasuo K: Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 72: 907-911, 1990
3. Baba T, Fukui S, Sakata S, Tashima T, Takeshita I, Nakamura T, Inoue T: Selective enhancement of intratumoral blood flow in malignant gliomas: Experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate. Acta Neurochir (Wien) 101: 66-74, 1989
4. Berk BC, Alexander RW, Brock TA, Gimbrone MA Jr Webb RC: Vasoconstriction: A new activity for platelet-derived growth factor. Science 232: 87-90, 1986
5. Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA Jr, Alexander RW: Epidermal growth factor, a vascular smooth muscle nitrogen, induces rat aortic contraction. J Clin Invest 75: 1083-1086, 1985
6. Betsholtz C, Heidin CH, Nister M, Ek B, Wasteson A, Westermark B: Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression of the cellular homologue to the transforming protein on simian sarcoma virus. Biochem Biophys Res Commun 117: 176-182, 1983
7. Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: Physiological and pharmocokinetic consideration. Semin Oncol 13: 70-82, 1986
8. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA 86: 2388-2392, 1989
9. Borgers M, Thone F, Verheyen A, Ter Keurs HEDJ: Localization of calcium in skeltal and cardiac muscle. Histochem J 16: 295-309, 1984
10. 9-bradykinin or of a-thrombin in rabbit aortic rings. Br J Pharmacol 105: 959-967, 1992
11. DiPolo R, Beaugé L: Physiological role of ATP-driven calcium pump in squid axon. Nature 278: 271-273, 1979
12. Edvinsson L, Johansson BB, Larsson B, MacKenzie ET, Skaa by T, Young AR: Calcium antagonist: effects on cerebral blood flow and blood-brain barrier permeability in the rat. Br J Pharmac 79: 141-148, 1983
13. Fross RD, Warnke PC, Groothuis DR: Blood flow and blood-to-tissue transport in 9L gliosarcoma: the role of the brain tumor model in drug delivery research. J Neuro-Oncol 11: 185-197, 1991
14. Levin VA: A pharmacologic basis for brain tumor chemotherapy. Semin Oncol 2: 57-61, 1975
15. Merkel LA. Rivera LM, Colussi DJ, Perrone MH: Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864. Biochemical and Biophysical Research Communications 192: 1319-1326, 1993
16. 2+-mobilizing actions of platelet-derived growth factor differ from those of bombesin and vasopressin in Swiss 3T3 mouse cells. Proc Natl Acad Sci USA 84: 5768-5772, 1987
17. Saburo MD, Thomas B: Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinese(s). J Pharmacol Exp Ther 267: 1119-1125, 1993
18. Murphy RA, Aksoy MO, Dillon PF, Gerthoffer WT, Kamm KE: The role of myosin light chain phosphorylation in reguration of the cross-bridge cycle. Fed Proc 42: 51-56, 1983
19. Nakamura K, Asami M, Kawada K, Sasahara K: Quantitative determination of ACNU (3-[4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride), a new water-soluble anti-tumor nitrosourea, in biological fluids and tissues of patients by high-performance liquid chromatography. Analytical method and pharmacokinetics. Ann Rep Sankyo Res Lab 29: 66-74, 1977
20. Neuwelt EA, Barnett PA, Binger DD, Frenkel EP: Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc Natl Acad Sci USA 79: 4420-4423, 1982
21. Neuwelt EA, Frenkel EP, Diehhl J, Vu LH, Rapoport S, Hill S: Reversible osmotic blood-brain barrier disruption in humans: Implications for the chemotherapy of malignant brain tumors. Neurosurgery 7: 44-52, 1980
22. Nister M, Heldin CH, Wasteson A, Westermark B: A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. Proc Natl Acad Sci USA 81: 926-930, 1984
23. Panter LA, Baumbach GL, Bigner DD et al.: Vasoactive drugs produce selective changes in flow to experimental brain tumors. Ann Neurol 18: 712-715, 1985
24. 2+ pump. In: Cheung WY (ed.) Academic Press; New York, 1983; Vol.4, pp 100-149
25. Rhodin JAG: The ultrastructure of mammalian arterioles and precapillary sphincters. J Ultrastruc Res 18: 181-223, 1967
26. San-Galli F, Vrignaud P, Robert J, Coindre JM, Cohadon F: Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats. J Neuro-Oncol 7: 299-304, 1989
27. 14C-alpha-aminoisobutyric acid in rat C6 glioma. J Neuro-Oncol 8: 197-204, 1990
28. Sherry JMF, Gorecka A, Aksoy MO, Dabrowska R, Hartshorne DJ: Role of calcium and phosphorylation in the reguration of the activity of gizzard myosin. Biochemistry 17: 4411-4418, 1978
29. Shigehara E, Tanaka M: Whole-body autoradiographic studies on tissue distribution of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl[1-(2-chloroethyl)-1-nitrosourea hydrochloride in tumor-bearing mice and rats. Gann 69: 907-914, 1978
30. 2+ regulation of mammalian smooth muscle actomyosin via a kinase-phosphate-dependent phosphorylation and dephosphorylation of the 20000-Mr light chain of myosin. Eur J Biochem 76: 521-530, 1977
31. Terada T, Miyamoto K, Hyotano G, Tsuura M, Nakamura Y, Nishiguchi T, Itakura T, Hayashi S, Komai N: Local blood flow changes in malignant brain tumors under induced hypertension. Acta Neurochir 118: 108-111, 1992
32. Westermark B, Nister M, Heldin CH: Growth factors and oncogenes in human malignant glioma. Neurol Clin 3: 785-799, 1985